Laguna Biotherapeutics, Inc. (Laguna), a biotechnology company focused on novel live bacterial therapeutics, today announced its upcoming presentation schedule for two premier industry conferences in the first half of 2026. The company will showcase data on its therapeutic platform at the Keystone Symposia and feature executive commentary on frontier technologies at Capital Factory's Health Supernova.
The details for the upcoming presentations are as follows:
Keystone Symposia: Cancer Immunotherapy: Basic Mechanisms Informing Clinical Applications & Combinations
Date: March 16, 2026
Location: Fairmont Le Chateau Frontenac, Quebec City, Quebec
Format: Poster Presentation
Overview: Jonathan Kotula, Ph.D., CEO and co-founder of Laguna, will present scientific findings highlighting the mechanisms and potential applications of the company's live bacterial immunotherapy approach.
Capital Factory’s Health Supernova
Date: May 13–14, 2026
Location: STATION Austin, Austin, TX
Format: Invited Presentation
Overview: Jonathan Kotula, Ph.D., CEO and co-founder of Laguna, has been invited to present the company’s novel approach to frontier technologies in life sciences and drug discovery.
"We are honored to be selected to present at these distinguished events alongside leaders across cancer research and health technology," said Jonathan Kotula, Ph.D., CEO of Laguna. "These conferences offer an ideal forum to share our scientific progress, connect with partners and peers, and highlight how our platform is advancing novel solutions for complex immunologic targets."
About Laguna Biotherapeutics, Inc. (Laguna)
Laguna is a privately funded, clinical-stage biotechnology company headquartered in San Francisco, CA with research labs in Siena, Italy. It is focused on developing novel therapeutics that activate and expand the immune system to create impactful treatments across oncology, as well as inflammatory and infectious diseases.
